BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27260108)

  • 1. Autologous Blood Transfusion in Sports: Emerging Biomarkers.
    Salamin O; De Angelis S; Tissot JD; Saugy M; Leuenberger N
    Transfus Med Rev; 2016 Jul; 30(3):109-15. PubMed ID: 27260108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection methods for autologous blood doping.
    Segura J; Monfort N; Ventura R
    Drug Test Anal; 2012 Nov; 4(11):876-81. PubMed ID: 22407819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current strategies of blood doping detection.
    Pottgiesser T; Schumacher YO
    Anal Bioanal Chem; 2013 Dec; 405(30):9625-39. PubMed ID: 23934350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin as a new biomarker for detecting autologous blood transfusion.
    Leuenberger N; Barras L; Nicoli R; Robinson N; Baume N; Lion N; Barelli S; Tissot JD; Saugy M
    Am J Hematol; 2016 May; 91(5):467-72. PubMed ID: 26822428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood doping: potential of blood and urine sampling to detect autologous transfusion.
    Segura J; Lundby C
    Br J Sports Med; 2014 May; 48(10):837-41. PubMed ID: 24764552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of autologous blood transfusions in athletes: a historical perspective.
    Mørkeberg J
    Transfus Med Rev; 2012 Jul; 26(3):199-208. PubMed ID: 22119492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OMICS-strategies and methods in the fight against doping.
    Reichel C
    Forensic Sci Int; 2011 Dec; 213(1-3):20-34. PubMed ID: 21862249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary di-(2-ethylhexyl) phthalate metabolites for detecting transfusion of autologous blood stored in plasticizer-free bags.
    Leuenberger N; Barras L; Nicoli R; Robinson N; Baume N; Lion N; Barelli S; Tissot JD; Saugy M
    Transfusion; 2016 Mar; 56(3):571-8. PubMed ID: 26581034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the trail of blood doping-microRNA fingerprints to monitor autologous blood transfusions in vivo.
    Mussack V; Wittmann G; Pfaffl MW
    Am J Hematol; 2021 Mar; 96(3):338-353. PubMed ID: 33326140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing.
    Solymos E; Guddat S; Geyer H; Flenker U; Thomas A; Segura J; Ventura R; Platen P; Schulte-Mattler M; Thevis M; Schänzer W
    Anal Bioanal Chem; 2011 Aug; 401(2):517-28. PubMed ID: 21188579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasticizers excreted in urine: indication of autologous blood transfusion in sports.
    Monfort N; Ventura R; Platen P; Hinrichs T; Brixius K; Schänzer W; Thevis M; Geyer H; Segura J
    Transfusion; 2012 Mar; 52(3):647-57. PubMed ID: 21895677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next Generation "Omics" Approaches in the "Fight" against Blood Doping.
    Wang G; Karanikolou A; Verdouka I; Friedmann T; Pitsiladis Y
    Med Sport Sci; 2017; 62():119-128. PubMed ID: 28571016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood transfusions in athletes. Old dogmas, new tricks.
    Lippi G; Banfi G
    Clin Chem Lab Med; 2006; 44(12):1395-402. PubMed ID: 17163813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting Autologous Blood Transfusion in Doping Control: Biomarkers of Blood Aging and Storage Measured by Flow Cytofluorimetry.
    Donati F; Acciarini R; De Benedittis I; de la Torre X; Pirri D; Prete M; Stampella A; Vernucci E; Botre F
    Curr Pharm Biotechnol; 2018; 19(2):124-135. PubMed ID: 29621963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whispers in the Blood: Leveraging MicroRNAs for Unveiling Autologous Blood Doping in Athletes.
    Hassanpour M; Salybekov AA
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood doping: the flip side of transfusion and transfusion alternatives.
    Cacic DL; Hervig T; Seghatchian J
    Transfus Apher Sci; 2013 Aug; 49(1):90-4. PubMed ID: 23791798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous Doping with Cryopreserved Red Blood Cells - Effects on Physical Performance and Detection by Multivariate Statistics.
    Malm CB; Khoo NS; Granlund I; Lindstedt E; Hult A
    PLoS One; 2016; 11(6):e0156157. PubMed ID: 27284981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of RBC-microparticles in stored whole blood bags - a promising marker to detect blood doping in sports?
    Voss SC; Jaganjac M; Al-Thani AM; Grivel JC; Raynaud CM; Al-Jaber H; Al-Menhali AS; Merenkov ZA; Alsayrafi M; Latiff A; Georgakopoulos C
    Drug Test Anal; 2017 Nov; 9(11-12):1794-1798. PubMed ID: 28474406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.
    Schumacher YO; Saugy M; Pottgiesser T; Robinson N
    Drug Test Anal; 2012 Nov; 4(11):846-53. PubMed ID: 22374784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.